As the expression of PKDkd increased glucose sensitivity and decreased insulin resistance in a HFD model, we tested if pharmacological PKD inhibition would be beneficial in an already existing HFD-induced insulin and glucose intolerance setting as well (Figure 6A). This evidence concerns the gene PRKD1 and Glucose intolerance.